Showing results (241-250 of 291) with videos related to

Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|August 3, 1999
Acyclovir is phosphorylated by the human cytomegalovirus UL97 proteinC L Talarico, T C Burnette, W H Miller, et al.
Investigational New Drugs|March 4, 2005
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials GroupG Goss, H Hirte, W H Miller, et al.
Oncogene|June 10, 2014
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3N Robichaud, S V del Rincon, B Huor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trialJ Rodon, J C Soria, R Berger, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activityS M Daluge, S S Good, M B Faletto, et al.
Gynecologic Oncology|July 14, 2022
Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 studyD M O'Malley, G M Bariani, P A Cassier, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimeticsR M Keenan, W H Miller, L S Barton, et al.
Journal of the National Cancer Institute|February 5, 1998
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cellsW Shao, M Fanelli, F F Ferrara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2014
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazineJ-J Grob, M M Amonkar, S Martin-Algarra, et al.
Cancer Research|February 2, 1999
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activityN Suh, Y Wang, T Honda, et al.
Pageof 30